Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: N15SW1DIV8

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Activin receptor type-2B antagonist PubMed
Primary Target
activin A receptor type 2B

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myositis, Inclusion Body 3 D018979 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Cachexia 2 D002100 ClinicalTrials
Sarcopenia 2 D055948 ClinicalTrials
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials
Muscular Atrophy 2 D009133 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1356922-05-8
ChEMBL CHEMBL3137353
FDA SRS N15SW1DIV8
Guide to Pharmacology 8086